Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOAC) have replaced vitamin K antagonist (VKA) oral anticoagulants as the first-line treatment option for stroke prevention in high-risk patients with atrial fibrillation. With VKA therapy, disease and treatment-related knowledge is associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Valery, Jose Raul, Marar, Ahmad, Pujalte, George, Ward, Cynthia, Abdelmoneim, Yousif M., Fitzgerald, Patrick J., Mwakyanjala, Edson, Harris, Dana M., Murray, Loren, Heckman, Michael G., White, Launia J., Stancampiano, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424872/
https://www.ncbi.nlm.nih.gov/pubmed/36000450
http://dx.doi.org/10.1177/21501319221118806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424872/
https://www.ncbi.nlm.nih.gov/pubmed/36000450
http://dx.doi.org/10.1177/21501319221118806

Ejemplares similares